flora68 wrote: .......I've noticed one important bit of misinformation about this situation that's popped up more than once today in news articles and in posts....regarding PML, the condition that caused the sudden halt in Tysabri use. Hopefully this error was totally inadvertant, but my cynical side won't rule out the possiblilty that this little mis-statement might have been a deliberate attempt at damage control .
PML is not, I repeat, NOT "sometimes fatal" or "frequently fatal". It's always, always 100% fatal. And rapidly fatal at that. Almost all PML patients succumb within 1-4 months of diagnosis.
Interesting info you posted on PML and the response by Elan.
I don't know how many times I commented on the mistrust I had about Biogen/Elan and the poor reputation Biogen in particular had within the medical community when it came to honest data reporting....
Harry, do you know of any particular reason to believe that Biogen/Elan is, well, more ethically-challenged than, say, the other MS drug makers like TEVA? Or major manufacturers of other meds as in Merck or Bayer?
Users browsing this forum: No registered users